¿Por qué debemos preocuparnos de diagnosticar una diabetes monogénica?

1997, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183 Fajans, 1960, Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus, Diabetes, 9, 83, 10.2337/diab.9.2.83 Fajans, 2011, MODY. History, genetics, pathophysiology, and clinical decision making, Diabetes Care, 34, 1878, 10.2337/dc11-0035 Stoffel, 1996, A yeast artificial chromosome-based map of the region of chromosome 20 containing the diabetes-susceptibility gene, MODY1, and a myeloid leukemia related gene, Proc Natl Acad Sci U S A, 93, 3937, 10.1073/pnas.93.9.3937 1997, An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains, Nat Genet, 17, 399, 10.1038/ng1297-399 Bennett, 2001, The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat Genet, 27, 20, 10.1038/83713 Rubio-Cabezas, 2009, Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes, Diabetes Care, 32, 111, 10.2337/dc08-1188 Biason-Lauber, 2013, Identification of a SIRT1 mutation in a family with type 1 diabetes, Cell Metab, 17, 448, 10.1016/j.cmet.2013.02.001 Moller, 1991, Insulin resistance — Mechanisms, syndromes, and implications, N Engl J Med, 325, 938, 10.1056/NEJM199109263251307 Kahn, 1976, The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man, N Engl J Med, 294, 739, 10.1056/NEJM197604012941401 Rabson, 1956, Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus; report of 3 cases, Am J Clin Pathol, 26, 283, 10.1093/ajcp/26.3.283 Kosztolányi, 1997, Leprechaunism/Donohue syndrome/insulin receptor gene mutations: A syndrome delineation story from clinicopathological description to molecular understanding, Eur J Pediatr, 156, 253, 10.1007/s004310050594 Thanabalasingham, 2011, Diagnosis and management of maturity onset diabetes of the young (MODY), BMJ, 343, d6044, 10.1136/bmj.d6044 Irgens, 2013, Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry, Diabetologia, 56, 1512, 10.1007/s00125-013-2916-y Edghill, 2006, HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months, Diabetes, 55, 1895, 10.2337/db06-0094 Massa, 2005, KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes, Hum Mutat, 25, 22, 10.1002/humu.20124 Hattersley, 2006, ISPAD Clinical Practice Consensus Guidelines 2006-2007. The diagnosis and management of monogenic diabetes in children, Pediatr Diabetes, 7, 352, 10.1111/j.1399-5448.2006.00217.x Edghill, 2008, Insulin mutation screening in 1,044 patients with diabetes: Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood, Diabetes, 57, 1034, 10.2337/db07-1405 Rubio-Cabezas, 2011, Permanent neonatal diabetes mellitus — The importance of diabetes differential diagnosis in neonates and infants, Eur J Clin Invest, 41, 323, 10.1111/j.1365-2362.2010.02409.x Shield, 2004, An assessment of pancreatic endocrine function and insulin sensitivity in patients with transient neonatal diabetes in remission, Arch Dis Child Fetal Neonatal Ed, 89, F341, 10.1136/adc.2003.030502 Gloyn, 2004, Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes, N Engl J Med, 350, 1838, 10.1056/NEJMoa032922 McCarthy, 2008, Learning from molecular genetics: Novel insights arising from the definition of genes for monogenic and type 2 diabetes, Diabetes, 57, 2889, 10.2337/db08-0343 Temple, 2010, 6q24 transient neonatal diabetes, Rev Endocr Metab Disord, 11, 199, 10.1007/s11154-010-9150-4 Diatloff-Zito, 2007, Genetic and epigenetic defects at the 6q24 imprinted locus in a cohort of 13 patients with transient neonatal diabetes: New hypothesis raised by the finding of a unique case with hemizygotic deletion in the critical region, J Med Genet, 44, 31, 10.1136/jmg.2006.044404 Aguilar-Bryan, 2008, Neonatal diabetes mellitus, Endocr Rev, 29, 265, 10.1210/er.2007-0029 Flanagan, 2007, Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood, Diabetes, 56, 1930, 10.2337/db07-0043 Thanabalasingham, 2012, Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young, Diabetes Care, 35, 1206, 10.2337/dc11-1243 Osbak, 2009, Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia, Hum Mutat, 30, 1512, 10.1002/humu.21110 Fajans, 2006, Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees, Diabetologia, 49, 1106, 10.1007/s00125-006-0158-y Iwabuchi, 2013, Japanese boy with maturity-onset diabetes of the young type 3 who developed diabetes at 19 months old, Pediatr Int Off J Jpn Pediatr Soc, 55, e32, 10.1111/j.1442-200X.2012.03741.x Pruhova, 2013, Two cases of diabetic ketoacidosis in HNF1A-MODY linked to severe dehydration: Is it time to change the diagnostic criteria for MODY?, Diabetes Care, 36, 2573, 10.2337/dc13-0058 Pontoglio, 2000, Hepatocyte nuclear factor1, a transcription factor at the crossroads of glucose homeostasis, J Am Soc Nephrol Jasn, 11, S140, 10.1681/ASN.V11suppl_2s140 Pearson, 2003, Genetic cause of hyperglycaemia and response to treatment in diabetes, Lancet, 362, 1275, 10.1016/S0140-6736(03)14571-0 Pearson, 2007, Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene, Plos Med, 4, e118, 10.1371/journal.pmed.0040118 Stanescu, 2012, Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A, J Clin Endocrinol Metab, 97, E2026, 10.1210/jc.2012-1356 Bellanné-Chantelot, 2004, Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations, Ann Intern Med, 140, 510, 10.7326/0003-4819-140-7-200404060-00009 Yorifuji, 2004, Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: Phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism, J Clin Endocrinol Metab, 89, 2905, 10.1210/jc.2003-031828 Bonnefond, 2012, Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene, Plos One, 7, e37423, 10.1371/journal.pone.0037423 Bowman, 2012, Heterozygous ABCC8 mutations are a cause of MODY, Diabetologia, 55, 123, 10.1007/s00125-011-2319-x Murphy, 2008, Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation, Diabet Med J Br Diabet Assoc, 25, 383, 10.1111/j.1464-5491.2008.02359.x Soriguer, 2012, Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The [email protected] Study, Diabetologia, 55, 88, 10.1007/s00125-011-2336-9 Thanabalasingham G, Shah N, Vaxillaire M, Hansen T, Tuomi T, Gašperíková D, et al. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia. 2011;54:2801-2810. Besser, 2011, Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1α/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type1 diabetes, Diabetes Care, 34, 286, 10.2337/dc10-1293 Thanabalasingham, 2013, Mutations in HNF1A result in marked alterations of plasma glycan profile, Diabetes, 62, 1329, 10.2337/db12-0880 Bonner, 2013, Identification of circulating microRNAs in HNF1A-MODY carriers, Diabetologia, 56, 1743, 10.1007/s00125-013-2939-4 Thanabalasingham, 2013, Atypical phenotype associated with reported GCK exon 10 deletions: Clinical judgement is needed alongside appropriate genetic investigations, Diabet Med, 30, e233, 10.1111/dme.12210